EASI Score Calculator

The Eczema Area and Severity Index (EASI) combines the physical intensity of eczema symptoms with the percentage of body surface area affected across four major body regions: the head and neck, trunk, upper limbs, and lower limbs. First, a clinical severity score is calculated for each region by summing the grade (0 to 3) of four cardinal signs: redness (erythema), thickness (induration/papulation), scratching (excoriation), and skin hardening (lichenification). Each region's severity score is then multiplied by an area score reflecting the percentage of that region involved (graded from 0 to 6), and further weighted by a regional multiplier that adjusts for age differences in body surface area distribution. Finally, the weighted regional scores are summed to yield a final EASI score ranging from 0 to 72.

Consider an adult patient (age 30) presenting with atopic dermatitis. For the trunk region, the clinician grades the physical signs as follows: redness is rated 2, thickness is rated 2, scratching is rated 1, and lichenification is rated 1. This gives a trunk severity score of 2 + 2 + 1 + 1 = 6. Suppose the trunk area score is graded as 3 (representing 30% to 49% body surface area involvement). Using the standard adult trunk multiplier of 0.3, the partial score for the trunk becomes 6 multiplied by 3 multiplied by 0.3, which equals 5.4. Similar calculations are performed for the head and neck, upper limbs, and lower limbs. When all four regional products are summed together, the patient yields a total composite EASI score, providing a clear benchmark for evaluating topical or systemic therapy efficacy.

When evaluating skin intensity signs, ensure you examine representative areas rather than isolated severe spots to maintain consistency. Always verify the patient's exact age before inputting data, as infants and toddlers under two years old have different regional body surface area multipliers compared to older children and adults. Regularly comparing baseline EASI scores with follow-up measurements provides objective proof of whether a therapeutic intervention is successfully controlling the inflammatory burden.